loadpatents
Patent applications and USPTO patent grants for Sippy; Bradford C..The latest application filed is for "d9-caffeine compositions and uses thereof".
Patent | Date |
---|---|
D9-caffeine Compositions And Uses Thereof App 20220288083 - Sippy; Bradford C. | 2022-09-15 |
Treatment Of Viral Hemorrhagic Fevers With Etoricoxib App 20220273609 - SIPPY; Bradford C. ;   et al. | 2022-09-01 |
Deuterated Caffeine And Uses Thereof App 20220248720 - Sippy; Bradford C. | 2022-08-11 |
Deuterated Caffeine And Uses Thereof App 20220225642 - Sippy; Bradford C. | 2022-07-21 |
Deuterated Forms Of Testosterone And Methods Of Use App 20220175796 - Sippy; Bradford C. ;   et al. | 2022-06-09 |
Method of treatment based on reduced monoamine oxidase a activity Grant 11,344,564 - Sippy May 31, 2 | 2022-05-31 |
Deuterated Forms Of Acetaminophen And Uses Thereof App 20220160660 - Sippy; Bradford C. | 2022-05-26 |
Aqueous Formulations Of Water Insoluble Cox-2 Inhibitors App 20220125773 - SIPPY; Bradford C. ;   et al. | 2022-04-28 |
Novel Dosage Forms Of Rofecoxib And Related Methods App 20220047542 - Sippy; Bradford C. ;   et al. | 2022-02-17 |
Deuterated forms of testosterone and methods of use Grant 11,202,785 - Sippy , et al. December 21, 2 | 2021-12-21 |
Deuterated Caffeine And Uses Thereof App 20210378266 - Sippy; Bradford C. | 2021-12-09 |
Deuterated etoricoxib, methods of manufacture, and use thereof Grant 11,161,833 - Sippy November 2, 2 | 2021-11-02 |
Ingestible Product and a Method of Using the Same App 20210244672 - Sippy; Bradford C. | 2021-08-12 |
Purified Forms Of Rofecoxib, Methods Of Manufacture And Use App 20210236455 - Skwierczynski; Raymond D. ;   et al. | 2021-08-05 |
Novel Dosage Forms Of Rofecoxib And Related Methods App 20210169845 - Sippy; Bradford C. ;   et al. | 2021-06-10 |
Novel Dosage Forms Of Rofecoxib And Related Methods App 20210137878 - Sippy; Bradford C. ;   et al. | 2021-05-13 |
Purified forms of rofecoxib, methods of manufacture and use Grant 10,987,337 - Skwierczynski , et al. April 27, 2 | 2021-04-27 |
Dosage forms of rofecoxib and related methods Grant 10,945,992 - Sippy , et al. March 16, 2 | 2021-03-16 |
Deuterated Caffeine And Uses Thereof App 20210068429 - Sippy; Bradford C. | 2021-03-11 |
Deuterated Caffeine And Uses Thereof App 20200390128 - Sippy; Bradford C. | 2020-12-17 |
Treatment Of Viral Hemorrhagic Fevers With Etoricoxib App 20200323830 - SIPPY; Bradford C. ;   et al. | 2020-10-15 |
Treatment Of Viral Hemorrhagic Fevers With Cox-2 Selective Non-steroidal Anti-inflammatory Drugs App 20200323813 - SIPPY; Bradford C. ;   et al. | 2020-10-15 |
Deuterated caffeine and uses thereof Grant 10,765,130 - Sippy Sep | 2020-09-08 |
Purified Forms Of Rofecoxib, Methods Of Manufacture And Use App 20200206182 - SIPPY; Bradford C. ;   et al. | 2020-07-02 |
Deuterated caffeine and uses thereof Grant 10,582,716 - Sippy | 2020-03-10 |
Ingestible Product And A Method Of Using The Same App 20190083405 - SIPPY; BRADFORD C. | 2019-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.